Clinical Conversation: Novel Mechanical Aspiration Thrombectomy in Patients With Acute Pulmonary Embolism: Results From the Prospective APEX-AV Trial-Clinical Conversation: Novel Mechanical Aspiration Thrombectomy in Patients With Acute Pulmonary Embolism: Results From the Prospective APEX-AV Trial

Clinical Conversation: Novel Mechanical Aspiration Thrombectomy in Patients With Acute Pulmonary Embolism: Results From the Prospective APEX-AV Trial

Back to course

Video Transcription

Video Summary

In a discussion focused on the innovative field of pulmonary embolism treatment, Dr. Sahil Parikh, Dr. Mona Ranade, Dr. Brent Keeling, and Dr. Ken Rosenfeld discuss findings from the APEX-AV trial. The trial evaluated the effectiveness of a novel aspiration thrombectomy device for treating acute PE patients. The results showed a significant reduction in RV to LV ratio and clot burden, indicating the device's potential in the field. Dr. Ranade highlighted the device's design features that facilitate clot removal, while Dr. Rosenfeld praised the trial's rapid completion and the collaboration between industry and scientific organizations, particularly the PERT Consortium. Challenges such as the need for head-to-head comparative trials and enhanced imaging techniques were discussed, with experts agreeing on the necessity of further research to refine treatment selections for patients. The conversation underscored current advancements and future possibilities in PE treatment.

Keywords

pulmonary embolism

APEX-AV trial

aspiration thrombectomy

PERT Consortium

treatment advancements